Global Cough Syrup Market Report (2022 to 2028) - Featuring AstraZeneca, Abbott Laboratories, Acella Pharmaceuticals and Glenmark Pharmaceuticals Among Others

01 Jul 2022
www.prnewswire.com
VaccineAcquisition
DUBLIN, July 1, 2022 /PRNewswire/ -- The "Global Cough Syrup Market 2022-2028" report has been added to
ResearchAndMarkets.com's offering.
The global cough syrup market is anticipated to register growth at a CAGR of 3.27% over the forecasted period of 2022-2028.
The rising prevalence of chronic respiratory diseases and surge in the geriatric population drives the cough syrup market's growth globally. Additionally, the rise in child-friendly cough syrup flavors, coupled with a growing preference for homeopathic cough syrups, creates new opportunities for the studied market.
On the contrary, overdose risk and stringent government rules and restrictions impede the cough syrup market's growth to a large extent.
The global cough syrup market covers North America, Asia-Pacific, Latin America, Europe, and the Middle East and Africa regions.
Geographically, the Asia-Pacific is anticipated to witness the fastest growth over the forecast period. The region's robust growth can be attributed to the rise in tobacco smoking, infection, and air pollution. The region's population is highly susceptible to issues such as TB, occupational lung diseases, and smoking-related conditions. Furthermore, asthma has become highly prevalent in the region due to the rise in air pollution and greenhouse farming methods. Populations in countries such as Japan, Thailand, and South Korea are vulnerable to numerous respiratory diseases. Thus, these factors augment the adoption and consumption of cough syrups.
COMPETITIVE OUTLOOK
Pfizer Inc is a research-based biopharmaceutical company involved in discovering, developing, and distributing healthcare products. Its business segments include biopharmaceuticals and Upjohn. The biopharma segment provides medicines, vaccines, and others for treating oncology, inflammatory, pneumococcal, and other rare diseases. The Upjohn segment offers products that treat non-communicable diseases across urology, cardiovascular, psychiatry, and others. Pfizer serves clients across the globe, including Asia-Pacific, Europe, the Middle East and Africa, and Latin America. It is headquartered in New York, the US.
Key Topics Covered:
1. Global Cough Syrup Market - Summary
2. Industry Outlook
2.1. Impact of Covid-19 on the Cough Syrup Market
2.2. Key Insights
2.2.1. Increasing Demand for Herbal Cough Syrups
2.2.2. Companies Provide Sugar-Free Cough Syrups
2.3. Porter'S Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitutes
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Threat of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Key Market Strategies
2.6.1. Mergers & Acquisitions
2.6.2. Divestitures
2.7. Market Drivers
2.7.2. Rise in Older Population
2.8. Market Challenges
2.8.1. Overdose Risk
2.8.2. Strict Government Regulations and Restrictions
2.9. Market Opportunities
2.9.1. Increase in Child-Friendly Cough Syrup Flavors
2.9.2. Growing Preference for Homeopathic Cough Syrups
2.9.3. Special Pediatric Cough Syrups
3. Global Cough Syrup Market Outlook - by Product Type
3.1. Cough Suppressants/Antitussives
3.2. Combination Medications
3.3. Expectorants
4. Global Cough Syrup Market Outlook - by Age Group
4.1. Adult
4.2. Pediatric
5. Global Cough Syrup Market Outlook - by Distribution Channel
6. Global Cough Syrup Market - Regional Outlook
7. Competitive Landscape
7.4. Cipla Limited
7.8. Johnson and Johnson
7.9. Merck Kgaa
7.12. Proctor and Gamble Co
7.14. Sanofi Sa
7.15. The Himalaya Drug Company
8. Research Methodology & Scope
For more information about this report visit https://www.researchandmarkets.com/r/a0yr22
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.